Association of TAP1 and TAP2 gene polymorphisms with systemic sclerosis in Korean patients

Human Immunology

Volumn 66, Issue 7, 2005, Pages 810-817

  Yeong, Wook Song ^a   Eun, Bong Lee ^a   Dong, Hee Whang ^b   Su, Jin Kang ^a   Takeuchi, Fujio ^c   Myoung, Hee Park ^a  

^a Seoul National University   (South Korea)

^b Inje University College of Medicine   (South Korea)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anti topoismerase I antibody; Systemic sclerosis; TAP1; TAP2

Indexed keywords

HLA DR ANTIGEN; PROTEIN; TOPOISOMERASE I ANTIBODY; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 1; TRANSPORTER ASSOCIATED WITH ANTIGEN PROCESSING 2; UNCLASSIFIED DRUG;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ETHNIC GROUP; FEMALE; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SYSTEMIC SCLEROSIS;

ADULT; AGED; ANTIBODIES; ATP-BINDING CASSETTE TRANSPORTERS; DNA TOPOISOMERASES, TYPE I, EUKARYOTIC; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; KOREA; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; RIBONUCLEOPROTEIN, U1 SMALL NUCLEAR; SCLERODERMA, DIFFUSE; SCLERODERMA, LIMITED; SCLERODERMA, SYSTEMIC;

EID: 23844519708     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2005.03.006     Document Type: Article

References (31)

1. T.A. Medsger Jr Systemic sclerosis (scleroderma) clinical aspects W.J. Koopman Arthritis and Allied Conditions 14th ed. 2001 Lippincott Williams & Wilkins Philadelphia
2. Y.J. Lee, K.C. Shin, S.W. Kang, E.B. Lee, H.A. Kim, Y.W. Song Type III procollagen N-terminal propeptide, soluble interleukin-2 receptor, and von Willebrand factor in systemic sclerosis Clin Exp Rheumatol 19 2001 69
3. S.H. Kang, M.H. Park, E.Y. Song, S.J. Kang, E.B. Lee, Y.W. Song, F. Takeuchi Association of HLA class II genes with systemic sclerosis in Koreans J Rheumatol 28 2001 1577
4. J.D. Reveille, E. Durban, M.J. MacLeod-St Clair, R. Goldstein, R. Moreda, R.D. Altman, F.C. Arnett Association of amino acid sequence in HLA-DQB1 first domain with antitopoisomerase I autoantibody response in scelroderma (progressive systemic sclerosis) J Clin Invest 90 1992 973
5. P.A. Morel, H.J. Chang, J.W. Wilson, C. Conte, S.L. Saidman, J.D. Bray, D.J. Tweardy, T.A. Medsger Jr Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele Hum Immunol 40 1994 101
6. G.C. Fanning, K.I. Welsh, C. Bunn, R.D. Bois, C.M. Black HLA association in three exclusive autoantibody subgroups in UK systemic sclerosis patients Br J Rheumatol 37 1998 201
7. M. Kuwana, J. Kaburaki, Y. Okano, H. Inoko, K. Tsuji The HLA-DR and DQ genes control the autoimmune response to DNA topoisomerase I in systemic sclerosis (scleroderma) J Clin Invest 92 1993 1296
8. F. Takeuchi, Y. Nakano, H. Yamada, G.H. Hong, H. Nabeta, A. Yoshida, K. Matsuda, M. Bannai, K. Tokunaga, K. Ito Association of HLA-DR with progressive systemic sclerosis in Japanese J Rheumatol 21 1994 857
9. F.C. Arnett, R.F. Howard, F. Tan, J.M. Moulds, W.B. Bias, E. Durban, H.D. Cameron, G. Paxton, T.J. Hodge, P.E. Weathers, J.D. Reveille Increased prevalence of systemic sclerosis in a Native American tribe in Oklahoma association with an Amerindian HLA haplotype Arthritis Rheum 39 1996 1362
10. J.D. Reveille, D. Owerbach, R. Goldstein, R. Moreda, R.A. Isern, F.C. Arnette Associaton of polar amino acid at position 26 of the HLA-DQB1 first domain with the anticentromere autoantibody response in systemic sclerosis (scleroderma) J Clin Invest 89 1992 1208
11. J.D. Reveille Molecular genetics of systemic sclerosis Curr Opin Rheumatol 7 1995 522
12. F.C. Arnette HLA and autoimmunity in scleroderma (systemic sclerosis) Int Rev Immunol 12 1995 107
13. M. Kuwana, H. Inoko, H. Kameda, T. Nojima, S. Sato, K. Nakamura, T. Ogasawara, M. Hirakata, Y. Ohosone, J. Kaburaki, Y. Okano, T. Mimori Association of human leukocyte antigen class II genes with autoantibody profiles, but not with disease susceptibility in Japanese patients with systemic sclerosis Intern Med 38 1999 336
14. C.A. Janeway P. Travers M. Walport M.J. Shlomchick Immunobiology 5th ed. 2001 Garland Publishing New York
15. A.Y. Huang, A.T. Bruce, D.M. Pardoll, H.I. Levitsky In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter Immunity 4 1996 349
16. M.S. Malnati, M. Marti, T. LaVaute, D. Jaraquemada, W. Biddison, R. DeMars, E.O. Long Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells Nature 357 1992 702
17. G. Kageyama, S. Kawano, S. Kanagawa, S. Kondo, M. Sugita, T. Nakanishi, A. Shimizu, S. Kumagai Effect of mutated transporters associated with antigen-processing 2 on characteristic major histocompatibility complex binding peptides analysis using electroscopy ionization tandem mass spectrometry Rapid Commun Mass Spectrom 18 2004 995
18. F. Takeuchi, S. Kuwata, K. Nakano, H. Nabeta, G.H. Hong, Y. Shibata, K. Tanimoto Association of TAP1 and TAP2 with systemic sclerosis in Japanese Clin Exp Rheumatol 14 1996 513
19. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee Preliminary criteria for the classification of systemic sclerosis (scleroderma) Arthritis Rheum 23 1980 581
20. E.Y. Song, M.H. Park, S.J. Kang, H.J. Park, B.C. Kim, K. Tokunaga, T. Akaza, T. Juji HLA class II allele and haplotype frequencies in Koreans based on 107 families Tissue Antigens 59 2002 475
21. S. Kuwata, M. Yanagisawa, H. Saeki, H. Nakagawa, T. Etoh, K. Tokunaga, T. Juji, Y. Shibata Lack of primary association between transporter associated with antigen processing genes and atopic dermatitis J Allergy Clin Immunol 96 1995 1051
22. H. Teisserenc, L. Besnault, I. Briaud, M. Busson, E. Albert, J.D. Bignon, L. Caraballo, D. Charron, P.M. Danze, L. Louie, B. Mora, G. Semana, S.H. Powis TAP, LMP and HLA-DM polymorphism 12th International Histocompatibility Workshop study D. Charron Genetic Diversity of HLA Functional and Medical Implication Vol 1 1997 EDK Paris
23. E. Maruya, Y. Ishikawa, L. Lin, K. Tokunaga, S. Kumagai, S. Yokoyama, H. Saji New polymorphisms within human TAP2 in the ATP-binding domain and profiles of TAP polymorphism in Japanese MHC 3 1996 1
24. S.G. Marsh, E.D. Albert, W.F. Bodmer, R.E. Bontrop, B. Dupont, H.A. Erlich, D.E. Geraghty, J.A. Hansen, B. Mach, W.R. Mayr, P. Parham, E.W. Petersdorf, T. Sasazuki, G.M. Schreuder, J.L. Strominger, A. Svejgaard, P.I. Terasaki Nomenclature for factors of the HLA system, 2002 Tissue Antigens 60 2002 407
25. S.H. Powis, S. Tonks, I. Mockridge, A.P. Kelly, J.G. Bodmer, J. Trowsdale Alleles and haplotypes of the MHC-encoded ABC trasporters TAP1 and TAP2 Immunogenetics 37 1993 373
26. 577), with susceptibility to Sjögren's syndrome Arthritis Rheum 40 1997 1685
27. S. Kanagawa, A. Morinobu, M. Koshiba, G. Kageyama, N. Hayashi, S. Yoshino, Y. Tokano, H. Hashimoto, S. Kumagai Association of the TAP2*Bky2 allele with presence of SS-A/Ro and other autoantibodies in Japanese patients with systemic lupus erythematosus Lupus 12 2003 258
28. J.M. Martin-Villa, J. Martinez-Laso, M.A. Moreno-Pelayo, M.J. Castro-Panete, N. Martinez-Quiles, M. Alvarez, M.D. de Juan, J.J. Gomez-Reino, A. Arnaiz-Villena Differential contribution of HLA-DR, DQ, and TAP2 alleles to systemic lupus erythematosus susceptibility in Spanish patients role of TAP2*01 alleles in Ro autoantibody production Ann Rheum Dis 57 1998 214
29. P.A. Correa, J.F. Molina, L.F. Pinto, M. Arcos-Burgos, M. Herrera, J.M. Anaya TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus Ann Rheum Dis 62 2003 363
30. J. Varga, J.H. Korn Pathogenesis emphasis of human data P.J. Clements D.E. Furst Systemic Sclerosis 2nd ed. 2004 Lippincott Williams & Wilkins Philadelphia
31. K.S. Barron, J.D. Reveille, M. Carrington, D.L. Mann, M.A. Robinson Susceptibility to Reiter's syndrome is associated with alleles of TAP genes Arthritis Rheum 38 1995 684